Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/30/2000CA2343067A1 Hairpin hybridizer molecules for modulation of gene expression
03/30/2000CA2343052A1 Methods of treating ige-associated disorders and compositions for use therein
03/30/2000CA2342976A1 Oral care compositions
03/30/2000CA2342957A1 Regulatory protein from human keratinocytes
03/30/2000CA2342742A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
03/30/2000CA2342607A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
03/30/2000CA2341241A1 Method of preventing acute lung injury
03/30/2000CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000CA2341036A1 Cyclic ester or amide derivatives
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000CA2310433A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparation containing pyridonecarboxylic acid and production method thereof
03/29/2000EP0989184A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
03/29/2000EP0989155A1 Powdery modified fillers containing rubber powder, method for the production and use thereof
03/29/2000EP0989137A2 Diagnostic agents for pancreatic exocrine function
03/29/2000EP0989127A1 An antifungal lactone compound
03/29/2000EP0989123A1 Benzimidazole derivative, hair growth promoter and external composition for skin using the same
03/29/2000EP0989121A1 Substituted benzamides and their use as immunomodulators
03/29/2000EP0989119A1 Process and intermediates for preparing trovafloxacin acid salts
03/29/2000EP0989112A2 Intermediates for the preparation of guanidinomethyl cyclohexane carboxylic acid ester derivatives
03/29/2000EP0989111A1 Derivatives of 10-hydroxy-2-decenoic acid and use in a composition favorable in the desquamation of the skin and composition containing the same
03/29/2000EP0988863A2 Stable complexes of poorly soluble compounds
03/29/2000EP0988860A1 NKT CELL ACTIVATORS CONTAINING $g(a)-GLYCOSYLCERAMIDES
03/29/2000EP0988856A2 Skin barrier function recovery and promotion composition and evaluation method thereof
03/29/2000EP0988797A1 Compositions for postgastrectomic mineral supply
03/29/2000EP0988548A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma
03/29/2000EP0988324A1 Method for manufacturing pure guar meal
03/29/2000EP0988321A2 B7-binding molecules for treating immune diseases
03/29/2000EP0988312A1 17$g(b)-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS
03/29/2000EP0988310A1 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
03/29/2000EP0988309A1 C-4''-substituted macrolide derivatives
03/29/2000EP0988308A1 9-oxime erythromycin derivatives
03/29/2000EP0988306A1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same
03/29/2000EP0988304A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
03/29/2000EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
03/29/2000EP0988302A1 Benzonaphthyridines
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988300A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988295A1 Heterocyclic substituted piperidines and uses thereof
03/29/2000EP0988292A2 Piperazine derivatives and their use as anti-inflammatory agents
03/29/2000EP0988285A1 Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp
03/29/2000EP0988282A2 Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
03/29/2000EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
03/29/2000EP0988274A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
03/29/2000EP0988108A1 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
03/29/2000EP0988061A1 Methods for delivering bioactive agents
03/29/2000EP0988059A2 Human quinone reductase 2 conjugates for adept and gdept
03/29/2000EP0988057A1 Drug targeting
03/29/2000EP0988042A1 A combination therapy for hiv infections
03/29/2000EP0988041A1 Use of dextran and other polysaccharides to improve mucus clearance
03/29/2000EP0988040A1 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
03/29/2000EP0988039A1 Topical application of opioid drugs such as morphine for relief of itching and skin disease or irritation
03/29/2000EP0988038A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
03/29/2000EP0988035A1 Caspases and apoptosis
03/29/2000EP0988034A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
03/29/2000EP0988033A1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol
03/29/2000EP0988032A1 IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
03/29/2000EP0988028A1 Therapeutically active compositions
03/29/2000EP0988020A2 Use of inorganic-organic hybrid prepolymers
03/29/2000EP0988009A1 Device and method for treatment of dysmenorrhea
03/29/2000EP0987997A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
03/29/2000EP0987942A1 Pharmaceutical composition and methods for using it
03/29/2000EP0886526A4 Protection of hemopoietic cells
03/29/2000EP0868420B1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity
03/29/2000EP0801554A4 Formulations and methods for reducing skin irritation
03/29/2000EP0783320A4 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/29/2000EP0778731B1 Ionene polymers containing biologically-active anions
03/29/2000EP0774949A4 Denture adhesive
03/29/2000EP0739343B1 Water soluble onium salt of taxo-diterpenoid
03/29/2000EP0735868B1 Use of non-steroidal cyclooxygenase inhibitors for the manufacture of a medicament for the treatment of elevated intraocular pressure
03/29/2000EP0734389B1 Rapamycin derivatives useful as immunosuppressants
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses
03/29/2000EP0697891B1 Polyoxime compounds and their preparation
03/29/2000EP0677171B1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders
03/29/2000EP0620733B1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof
03/29/2000EP0611302B1 Receptors for treating late phase inflammatory responses
03/29/2000EP0602123B1 Steroid sulphatase inhibitors
03/29/2000CN1248973A Oxazolidines as 5-HT2A-antagonists
03/29/2000CN1248971A Quinoxalinediones
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor
03/29/2000CN1248966A Aminobenzophenones as inhibitors of interleukin and TNF
03/29/2000CN1248918A Liver protection or treatment agents comprising astatic acid derivatives as the active component
03/29/2000CN1248917A Method of treating prostatic diseases using active vitamin danalogues
03/29/2000CN1248916A Use of FXR, PPAR 'alpha' and LXR 'alpha' activators to restore barrier function, promote epidermal differentiation and inhibit proliferation
03/29/2000CN1248915A Medicament against infertility and for increasing fertility
03/29/2000CN1248914A Pharmaceutical composition
03/29/2000CN1248913A Pharmaceutical composition for programmed release of dexfenfluramine
03/29/2000CN1248912A Oral preparation for prophylactic and therapeutic treatment of helicobacter sp. infection
03/29/2000CN1248907A Composition for enhancing skin or hair
03/29/2000CN1248583A Caryophyllin acid sodium and application in pharmacy thereof
03/29/2000CN1248581A Separation for cephalosporin isomer
03/29/2000CN1248580A Process for preparing monacid salt of tonorfloxacin
03/29/2000CN1248569A Novel ketone
03/29/2000CN1248466A Yuchuang oinment for treating sore
03/29/2000CN1248460A Medicine for treating burn (scald) and preparation process
03/29/2000CN1248452A Medicine for quick curing tympanitis and preparation process thereof
03/29/2000CN1248441A Apomorphine hydrochloride lozenge and usage thereof
03/29/2000CN1248440A Medicine for quick treating burn and scald and preparation method
03/29/2000CN1248439A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system
1 ... 6342 6343 6344 6345 6346 6347 6348 6349 6350 6351 6352 6353 6354 6355 6356 6357 6358 6359 6360 6361 6362 ... 7860